We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+13.93%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.19B
AUM Growth
+$22.1M
(+1.9%)
Cap. Flow
-$83.9M
Cap. Flow
% of AUM
-7.06%
Top 10 Holdings %
Top 10 Hldgs %
3.97%
Holding
2,047
New
610
Increased
399
Reduced
421
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$5.03M |
| 2 |
Aclaris Therapeutics
ACRS
|
+$4.73M |
| 3 |
UnitedHealth
UNH
|
+$4.35M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$4.05M |
| 5 |
Remitly
RELY
|
+$3.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teck Resources
TECK
|
+$5.81M |
| 2 |
Adobe
ADBE
|
+$4.57M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$4.14M |
| 4 |
Progyny
PGNY
|
+$4.14M |
| 5 |
Constellation Brands
STZ
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.56% |
| 2 | Technology | 13.55% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Financials | 12.97% |
| 5 | Industrials | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
LKQ Corp
LKQ
$6.29B
| $252K | 0.02% |
5,271
-13,483
| -72% | -$629K |
|
1202
Pulmonx
LUNG
$87.6M
| $252K | 0.02% |
+19,792
| New | +$206K |
|
1203
REX American Resources
REX
$1.41B
| $252K | 0.02% |
10,640
-3,472
| -25% | -$69.4K |
|
1204
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
| $251K | 0.02% |
2,391
| – | – |
|
|
OSG
1205
Octave Specialty Group
OSG
$222M
| $250K | 0.02% |
+15,183
| New | +$211K |
|
1206
Rapid7
RPD
$773M
| $250K | 0.02% |
4,381
-4,093
| -48% | -$214K |
|
1207
Nurix Therapeutics
NRIX
$2.65B
| $249K | 0.02% |
24,091
-171,329
| -88% | -$1.17M |
|
1208
Core Laboratories
CLB
$521M
| $248K | 0.02% |
+14,015
| New | +$282K |
|
|
IVAC
1209
DELISTED
Intevac Inc
IVAC
| $248K | 0.02% |
+57,415
| New | +$214K |
|
1210
Enterprise Products Partners
EPD
$81.7B
| $247K | 0.02% |
+9,367
| New | +$250K |
|
1211
Graco
GGG
$13.5B
| $247K | 0.02% |
2,843
-4,228
| -60% | -$332K |
|
|
KZR
1212
DELISTED
Kezar Life Sciences
KZR
| $247K | 0.02% |
+26,041
| New | +$229K |
|
1213
Truist Financial
TFC
$64B
| $247K | 0.02% |
6,691
-41,802
| -86% | -$1.31M |
|
1214
Univest Financial
UVSP
$1.18B
| $247K | 0.02% |
+11,228
| New | +$210K |
|
1215
Liquidity Services
LQDT
$1.32B
| $246K | 0.02% |
+14,272
| New | +$272K |
|
|
NRT
1216
North European Oil Royalty Trust
NRT
$81M
| $246K | 0.02% |
42,204
-1,952
| -4% | -$16.8K |
|
1217
Ooma
OOMA
$604M
| $246K | 0.02% |
22,898
-37,421
| -62% | -$425K |
|
1218
lululemon athletica
LULU
$14.6B
| $245K | 0.02% |
479
-640
| -57% | -$277K |
|
|
ARAV
1219
DELISTED
Aravive, Inc. Common Stock
ARAV
| $245K | 0.02% |
+1,977,407
| New | +$271K |
|
1220
Quanterix
QTRX
$190M
| $244K | 0.02% |
+8,908
| New | +$210K |
|
1221
RXO
RXO
$3.58B
| $244K | 0.02% |
10,492
-44,585
| -81% | -$897K |
|
1222
iShares Global Infrastructure ETF
IGF
$10.7B
| $243K | 0.02% |
+5,171
| New | +$230K |
|
1223
Symbotic
SYM
$5.22B
| $243K | 0.02% |
4,728
-5,772
| -55% | -$253K |
|
1224
Global X MSCI Argentina ETF
ARGT
$826M
| $242K | 0.02% |
+4,718
| New | +$212K |
|
1225
Arcutis Biotherapeutics
ARQT
$3.18B
| $242K | 0.02% |
+74,854
| New | +$203K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, GSA Capital Partners held 2,047 positions worth $1.19B, up 1.9% from $1.17B the previous quarter. Its ten largest holdings account for 4% of the portfolio.
GSA Capital Partners withdrew a net $83.9M in Q4 2023, closing 613 positions and reducing 421 holdings. Its most notable exit was Teck Resources, an estimated $5.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, GSA Capital Partners opened a new position in Aon worth $4.58M.
- GSA Capital Partners's largest Q4 2023 buy was Aon: 15,721 shares worth $4.58M.
- GSA Capital Partners added most to Aclaris Therapeutics in Q4 2023, an estimated $4.73M increase.
- GSA Capital Partners's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $3.48M.
- GSA Capital Partners fully exited Teck Resources in Q4 2023, selling an estimated $5.81M.
- GSA Capital Partners's ten largest holdings make up 4% of its $1.19B portfolio in Q4 2023.
- GSA Capital Partners opened 610 new positions and closed 613 in Q4 2023.
- GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.19B.
Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.